IDEFIRIX Product Sales Increased 83% Compared to the Prior Year LUND, Sweden, Feb. 6, 2025 /PRNewswire/ -- Hansa Biopharma AB, Hansa or the Company (Nasdaq Stockholm: HNSA) today announced its full year and Q4 2024 financial results. Søren Tulstrup, President and CEO, Hansa Biopharma...
Read More Details
Finally We wish PressBee provided you with enough information of ( Hansa Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results )
Also on site :
- At Least 11 Dead After Driver Plowed Into Crowd at a Filipino Festival in Vancouver
- What to know about the trial of an ex-Michigan cop charged in the killing of a Black motorist
- U.S. Military Says Its Air Campaign Has Hit More Than 800 Targets in Yemen